J&J Trying To Back Out Of 77 Risperdal Deals, Plaintiffs Say
By Matt Fair ( November 12, 2013, 6:46 PM EST) -- A group of nearly 80 plaintiffs pursuing lawsuits against a Johnson & Johnson subsidiary in Pennsylvania state court over injuries they allegedly suffered from the antipsychotic drug Risperdal said last week that the company was attempting to renege on settlement deals agreed to in January....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.